扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/30 | 2,984 | 2,984 | 2,941 | 2,951 | -26 | -0.9% | 5,600 |
2018/07/27 | 2,984 | 2,984 | 2,941 | 2,977 | +8 | +0.3% | 5,800 |
2018/07/26 | 2,943 | 2,975 | 2,896 | 2,969 | +49 | +1.7% | 6,600 |
2018/07/25 | 2,957 | 2,957 | 2,917 | 2,920 | -37 | -1.3% | 3,100 |
2018/07/24 | 2,985 | 2,987 | 2,943 | 2,957 | -23 | -0.8% | 3,500 |
2018/07/23 | 2,950 | 2,988 | 2,950 | 2,980 | +82 | +2.8% | 9,100 |
2018/07/20 | 2,900 | 2,900 | 2,877 | 2,898 | -9 | -0.3% | 13,500 |
2018/07/19 | 2,866 | 2,908 | 2,866 | 2,907 | +42 | +1.5% | 6,500 |
2018/07/18 | 2,865 | 2,866 | 2,845 | 2,865 | +38 | +1.3% | 6,900 |
2018/07/17 | 2,769 | 2,828 | 2,769 | 2,827 | +58 | +2.1% | 8,000 |
2018/07/13 | 2,760 | 2,775 | 2,756 | 2,769 | +31 | +1.1% | 4,800 |
2018/07/12 | 2,750 | 2,750 | 2,730 | 2,738 | +18 | +0.7% | 2,400 |
2018/07/11 | 2,701 | 2,735 | 2,691 | 2,720 | +33 | +1.2% | 6,400 |
2018/07/10 | 2,784 | 2,784 | 2,687 | 2,687 | -67 | -2.4% | 14,400 |
2018/07/09 | 2,779 | 2,784 | 2,726 | 2,754 | -10 | -0.4% | 4,800 |
2018/07/06 | 2,807 | 2,809 | 2,730 | 2,764 | -42 | -1.5% | 12,200 |
2018/07/05 | 2,801 | 2,830 | 2,801 | 2,806 | -23 | -0.8% | 3,400 |
2018/07/04 | 2,802 | 2,833 | 2,801 | 2,829 | +15 | +0.5% | 3,500 |
2018/07/03 | 2,817 | 2,842 | 2,814 | 2,814 | +1 | ±0% | 5,600 |
2018/07/02 | 2,911 | 2,911 | 2,813 | 2,813 | -98 | -3.4% | 5,400 |
2018/06/29 | 2,977 | 2,977 | 2,911 | 2,911 | -66 | -2.2% | 3,200 |
2018/06/28 | 2,951 | 2,982 | 2,918 | 2,977 | -8 | -0.3% | 5,500 |
2018/06/27 | 2,964 | 2,989 | 2,948 | 2,985 | +71 | +2.4% | 4,700 |
2018/06/26 | 2,984 | 2,984 | 2,900 | 2,914 | -20 | -0.7% | 2,600 |
2018/06/25 | 2,931 | 2,957 | 2,914 | 2,934 | -39 | -1.3% | 2,500 |
2018/06/22 | 2,991 | 2,991 | 2,951 | 2,973 | +32 | +1.1% | 2,200 |
2018/06/21 | 2,981 | 2,987 | 2,941 | 2,941 | -46 | -1.5% | 3,000 |
2018/06/20 | 2,988 | 2,988 | 2,960 | 2,987 | +8 | +0.3% | 7,400 |
2018/06/19 | 2,942 | 3,000 | 2,933 | 2,979 | +37 | +1.3% | 4,300 |
2018/06/18 | 2,974 | 2,997 | 2,940 | 2,942 | -32 | -1.1% | 4,900 |
2018/06/15 | 2,992 | 2,994 | 2,968 | 2,974 | -17 | -0.6% | 4,800 |
2018/06/14 | 2,947 | 2,991 | 2,946 | 2,991 | +46 | +1.6% | 3,100 |
2018/06/13 | 2,928 | 2,960 | 2,928 | 2,945 | +14 | +0.5% | 1,900 |
2018/06/12 | 2,962 | 2,962 | 2,921 | 2,931 | -11 | -0.4% | 2,300 |
2018/06/11 | 2,942 | 2,964 | 2,925 | 2,942 | ±0 | ±0% | 3,500 |
2018/06/08 | 2,895 | 2,944 | 2,895 | 2,942 | +11 | +0.4% | 7,600 |
2018/06/07 | 2,874 | 2,931 | 2,874 | 2,931 | +43 | +1.5% | 2,500 |
2018/06/06 | 2,945 | 2,988 | 2,886 | 2,888 | -83 | -2.8% | 4,800 |
2018/06/05 | 2,902 | 2,971 | 2,886 | 2,971 | +44 | +1.5% | 1,800 |
2018/06/04 | 2,912 | 2,929 | 2,892 | 2,927 | +24 | +0.8% | 3,700 |
2018/06/01 | 2,859 | 2,911 | 2,859 | 2,903 | -6 | -0.2% | 3,800 |
2018/05/31 | 2,902 | 2,917 | 2,897 | 2,909 | +3 | +0.1% | 3,500 |
2018/05/30 | 2,895 | 2,918 | 2,895 | 2,906 | -37 | -1.3% | 1,800 |
2018/05/29 | 2,975 | 2,975 | 2,927 | 2,943 | -62 | -2.1% | 2,600 |
2018/05/28 | 3,010 | 3,010 | 2,985 | 3,005 | +22 | +0.7% | 2,700 |
2018/05/25 | 2,973 | 2,991 | 2,966 | 2,983 | +25 | +0.8% | 1,800 |
2018/05/24 | 3,015 | 3,015 | 2,952 | 2,958 | -41 | -1.4% | 4,400 |
2018/05/23 | 3,015 | 3,015 | 2,976 | 2,999 | -16 | -0.5% | 3,200 |
2018/05/22 | 2,950 | 3,015 | 2,950 | 3,015 | -5 | -0.2% | 7,600 |
2018/05/21 | 3,030 | 3,030 | 2,996 | 3,020 | -10 | -0.3% | 6,000 |
1651~
1700
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 242,200円 | +8.3% | +98.1% | 3.39% | 7.96倍 | 0.55倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ダイト | 208,600円 | +4.5% | -33.7% | 3.36% | 20.86倍 | 0.61倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ミズホメディ | 151,400円 | +1.2% | -13.9% | 5.61% | 8.93倍 | 1.66倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
アンジェス | 6,800円 | +110.0% | - | 0.00% | - | 11.06倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
CANBAS | 100,600円 | - | - | 0.00% | - | 6.44倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム